aminopyrine has been researched along with s-nitroso-n-acetylpenicillamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, JF; Hanson, PJ; Whittle, BJ | 1 |
| Berg, A; Ericson, AC; Redeen, S; Sjöstrand, SE | 1 |
2 other study(ies) available for aminopyrine and s-nitroso-n-acetylpenicillamine
| Article | Year |
|---|---|
The nitric oxide donor, S-nitroso-N-acetyl-penicillamine, inhibits secretory activity in rat isolated parietal cells.
Topics: Adenosine Triphosphate; Aminopyrine; Animals; Cell Membrane Permeability; Cell Separation; Cyclic GMP; Dose-Response Relationship, Drug; Male; Nitric Oxide; Parietal Cells, Gastric; Penicillamine; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; Vasodilator Agents | 1993 |
Nitric oxide-an endogenous inhibitor of gastric acid secretion in isolated human gastric glands.
Topics: Adult; Aminopyrine; Arginine; Bucladesine; Carbon Radioisotopes; Enzyme Inhibitors; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Histamine; Humans; Immunohistochemistry; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Nitroprusside; S-Nitroso-N-Acetylpenicillamine | 2004 |